Multiple Sclerosis

Multiple sclerosis is a disease of the central nervous system, inflicting a wide range of relapsing symptoms, from muscle weakness to chronic pain and depression. Mostly diagnosed between the ages of 20 and 40, it affects almost twice as many women as men.

There is no cure for MS yet, but access to specialists and treatment helps people manage the condition.

More than 700,000 persons are affected directly by MS across European countries and many more citizens are affected indirectly as family members or carers.

The total costs of managing MS in Europe have been estimated at 15 billion euros per year. 

All the MS community can receive better and more timely support once suitable data infrastructures are in place. This is precisely EUReMS' mission: to create a better understanding of multiple sclerosis and enable positive results in MS management and research - in other words, better outcome with better data.

Find more about MS from:

  • The website of the European Multiple Sclerosis¨Platform (EMSP);
  • EMSP's MS Barometer 2013; 
  • A series of MS Factsheets compiled in support of the MS Barometer by one of EMSP's industry partners;
  • The website of EMSP's Under Pressure project.